11 - 20 out of 27Page size: 10
  1. 2017

  2. Depressive behaviour induced by activation of hippocampus associated with changes in c-Fos and Bcl-xL expression in the CA1 and cortical neurons

    Dygalo, N., Bulygina, V. V., Sukhareva, E. V., Kalinina, T. S. & Lanshakov, D. A., Oct 2017, In: European Neuropsychopharmacology. 27, p. S675-S675 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  3. Glucocorticoids reduce TPH2 expression in the neonatal rat brain

    Kalinina, T. S., Bulygina, V. V., Lanshakov, D. A., Sukhareva, E. V., Shishkina, G. T. & Dygalo, N. N., Oct 2017, In: European Neuropsychopharmacology. 27, p. S609-S609 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  4. 2018

  5. Doxycycline Used for Control of Transgene Expression has its Own Effects on Behaviors and Bcl-xL in the Rat Hippocampus

    Shishkina, G. T., Lanshakov, D. A., Bannova, A. V., Kalinina, T. S., Agarina, N. P. & Dygalo, N. N., 1 Jan 2018, In: Cellular and Molecular Neurobiology. 38, 1, p. 281-288 8 p.

    Research output: Contribution to journal › Article › peer-review

  6. Translocation of Oligonucleotide–Oligosaccharide Complexes into Cells of the Brain

    Dygalo, N. N., Kalinina, T. S. & Lanshakov, D. A., 1 Mar 2018, In: Doklady Biochemistry and Biophysics. 479, 1, p. 108-110 3 p., 15.

    Research output: Contribution to journal › Article › peer-review

  7. 2019

  8. Ketamine improves depressive symptoms caused by stress and induces c-Fos expression in the brain resembling some effects of stress

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., 2019, In: European Neuropsychopharmacology. 29, p. S212-S212 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  9. TpH2 expression after neonatal dexamethasone treatment and acute or chronic stress in adulthood

    Kalinina, T., Sukhareva, E., Lanshakov, D., Bulygina, V. & Dygalo, N., 2019, In: European Neuropsychopharmacology. 29, p. S222-S222 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  10. Expression of Neurotrophic Factor 3 in the Hippocampus of Neonatal Rats after Administration of Dexamethasone

    Bulygina, V. V., Kalinina, T. S., Lanshakov, D. A. & Dygalo, N. N., Oct 2019, In: Neurochemical Journal. 13, 4, p. 349-354 6 p.

    Research output: Contribution to journal › Article › peer-review

  11. Extrahypothalamic CRH and its receptors change tyrosine hydroxylase expression after neonatal dexamethasone treatment

    Sukhareva, E. V., Lanshakov, D., Kalinina, T., Bulygina, V. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S301-S302 2 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  12. Long-term up-regulation of tyrosine hydroxylase gene expression after neonatal dexamethasone

    Kalinina, T., Sukhareva, E., Bulygina, V., Lanshakov, D., Egorova, K. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S166-S167 6 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  13. Subanesthetic dose of ketamine relieves depression-like behavior induced by optogenetic stimulation of the hippocampal pyramidal neurons

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., Dec 2019, In: European Neuropsychopharmacology. 29, p. S94-S94 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

Previous 1 2 3 Next

ID: 19277923